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Abstract
Nitrotyrosination of proteins, a hallmark of inflammation, may result in the production of MHC-restricted neoantigens that
can be recognized by T cells and bypass the constraints of immunological self-tolerance. Here we biochemically and
structurally assessed how nitrotyrosination of the lymphocytic choriomeningitis virus (LCMV)-associated immunodominant
MHC class I-restricted epitopes gp33 and gp34 alters T cell recognition in the context of both H-2D
b and H-2K
b.
Comparative analysis of the crystal structures of H-2K
b/gp34 and H-2K
b/NY-gp34 demonstrated that nitrotyrosination of p3Y
in gp34 abrogates a hydrogen bond interaction formed with the H-2K
b residue E152. As a consequence the conformation of
the TCR-interacting E152 was profoundly altered in H-2K
b/NY-gp34 when compared to H-2K
b/gp34, thereby modifying the
surface of the nitrotyrosinated MHC complex. Furthermore, nitrotyrosination of gp34 resulted in structural over-packing,
straining the overall conformation and considerably reducing the stability of the H-2K
b/NY-gp34 MHC complex when
compared to H-2K
b/gp34. Our structural analysis also indicates that nitrotyrosination of the main TCR-interacting residue
p4Y in gp33 abrogates recognition of H-2D
b/gp33-NY complexes by H-2D
b/gp33-specific T cells through sterical hindrance.
In conclusion, this study provides the first structural and biochemical evidence for how MHC class I-restricted
nitrotyrosinated neoantigens may enable viral escape and break immune tolerance.
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Introduction
The biological function of proteins and cellular metabolism can
be significantly modulated through post-translational modifications
(PTMs) [1,2]. Naturally occurring PTMs can either result from
enzymemodificationsorarisespontaneously [3,4].However, PTMs
can also be used by bacterial and viral pathogens to compromise
critical immune responses and host factors acting against infection
[5].The breakdown of immunological toleranceresulting from such
modifications may render endogenous antigens immunogenic [3,6].
A large array of PTM peptides presented by major histocompat-
ibility complex (MHC) class I and class II molecules have now been
described [7,8], and it has been demonstrated that modifications
such as cysteinylation [9,10], glycosylation [11,12] or phosphory-
lation [13,14] may affect T cell immunoreactivity, resulting in
immune escape and/or initiation of autoimmunity.
Protein tyrosine nitration is a hallmark of inflammation, and is
associated with up-regulated expression of inducible nitric oxide
synthase (iNOS) [15,16]. Nitrotyrosinated proteins (NT-proteins)
are generated in vivo by nitration with peroxynitrite, itself derived
from nitric oxide and superoxide which are both released from
activated inflammatory cells [17]. NT-proteins may accumulate in
apoptotic or inflamed tissues [18]. Indeed, accumulation of the
amino acid homolog 39-nitrotyrosine (NY) and of NT-proteins has
been observed at inflammatory sites in Alzheimer’s disease [19],
arthritis [20,21,22,23], atherosclerosis [22,23], autoimmune dia-
betes [24], autoimmune uveitis [25], celiac disease [26], ischemia-
reperfusion injury [27], multiple sclerosis [28], Parkinson’s disease
[29], respiratory disease [30] and transplant rejection [31], as well
as in various cancers and infectious diseases [32]. NT self-proteins
may thus be highly immunogenic, eliciting both humoral and
cellular responses [17,33].
The potential immunogenicity of MHC class II-restricted NT
autologous peptides has been previously investigated using the I-
E
k-restricted T cell pigeon/moth cytochrome c (PCC/MCC88–103)
[34] as well as the I-A
k-restricted hen egg-white lysozyme (HEL)
epitopes [35]. Both studies demonstrated unequivocally that
conversion of tyrosine to nitrotyrosine resulted in dramatic
consequences for T cell recognition. Indeed, processing of native
proteins by activated antigen presenting cells (APCs) resulted in
the presentation of MHC class II-restricted NT-epitopes in
lymphoid tissues, significantly altering specific T cell responses
and eliciting NT-specific CD4
+ T cells that evaded negative
selection in the thymus and thus central tolerance [33]. Likewise
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32805loss of tolerance by NT-specific CD4
+ T cells has recently been
shown to be critical for the production of autoreactive antibodies
[36]. These studies indicate that NT-proteins generated during
inflammation might constitute an important class of neoantigens
that could promote autoimmune T cell responses.
The well-established lymphocytic choriomeningitis virus
(LCMV) glycoprotein system was also used by Hardy et al to
demonstrate that conversion of tyrosine to NY also profoundly
affected T cell recognition of MHC class I-restricted epitopes [37].
A significant amount of the overall CD8
+ T cell response to
LCMV is dominated by very few viral epitopes, comprising the H-
2D
b-and H-2K
b- restricted peptide gp33–41 (hereafter referred to
as gp33; KAVYNFATC) and the H-2K
b-restricted peptide gp34–
41 (gp34; AVYNFATC) [38,39]. Both gp33 and gp34 contain a
single tyrosine residue at positions 4 (p4Y) and 3 (p3Y),
respectively. T cell populations, exclusively specific to the




b/NY-gp34 [37], were elicited in C57/BL6
mice (H-2D
b+/H-2K
b+) following immunization with the nitrated
peptide NY-gp33. Importantly, CD8
+ T cell hybridomas specific
for NY-gp33 comprised two distinct subsets recognizing either H-
2D
b/NY-gp33 or H-2K
b/NY-gp33. While the T cell hybridoma
24H1 responded to stimulation with both H-2K
b/NY-gp34 andH-
2K
b/NY-gp33, it did not recognize the unmodified wild-type
MHC complex H-2K
b/gp34 nor H-2K
b/gp33 [37]. Similarly, the
H-2D
b/NY-gp33-specific T cell hybridoma 4C8 did not recognize
H-2D
b/gp33. In contrast, nitrotyrosination of the main T cell
receptor (TCR)-interacting peptide tyrosine residue p4Y abrogat-
ed recognition of H-2D
b/NY-gp33 MHC complexes by H-2D
b/
gp33-specific T cells from P14 transgenic mice [37].
The present study provides a comparative biochemical and
structural analysis that explains how nitrotyrosination of the
LCMV-associated immunodominant epitopes gp33 and gp34 can
alter T cell recognition in the context of the two different MHC
class I molecules H-2D
b and H-2K
b. Nitrotyrosination of the
MHC-restricted peptide impairs TCR recognition through
reduced stability and alteration of the molecular surface of the
MHC complex. The possible implications for the role of
nitrotyrosination in the creation of modified neoantigens that
allow for viral escape and/or breaking of immune tolerance that
possibly results in autoimmune disorders are discussed.
Materials and Methods
Preparation and crystallization of H-2K
bin complex with
gp34 and NY-gp34
Peptides gp34 (AVYNFATM) and NY-gp34 (AV-p3NY-
NFATM) were purchased from Genscript (Piscataway, NJ,
USA). Refolding and purification of MHC/peptide complexes
were followed according to previously published protocols
[40,41,42,43]. The best crystals for H-2K
b/gp34 and H-2K
b/
NY-gp34 were obtained in hanging drops by vapor diffusion in
2.1 M NaH2PO4/K2HPO4 (pH 6.4), 1.5% MPD and 1.8 M
NaH2PO4/K2HPO4 (pH 6.7), 1.5% MPD, respectively. Typical-
ly, 2 ml of 6 mg/ml protein were equilibrated against 2 mlo f
crystallization reservoir solution at 20uC.
Data collection and processing
Data collection was performed under cryogenic conditions
(temperature 100 K) at beam lines ID14-2 and ID14-4 at the
synchrotron radiation facility at ESRF (Grenoble, France) to a
resolution of 2.0 and 2.6 A ˚ for H-2K
b/gp34 and H-2K
b/NY-
gp34, respectively. Crystals were soaked in a cryoprotectant
solution containing 25% glycerol before data collection. A total of
180 and 360 images were collected with 0.5u oscillation per frame
for both H-2K
b/gp34 and H-2K
b/NY-gp34. Data were processed
with MOSFLM [44] and SCALA from the CCP4 suite [45]. The
space group was determined to be P212121 for H-2K
b/gp34 with
unit-cell parameters a=88.4, b=92.6, c=128.8 A ˚. The space
group for H-2K
b/NY-gp34 wasP21 with unit-cell parameters
a=50.5, b=88.5, c=119 A ˚, a=c=90.0u and b=94.7u. Data
collection statistics are provided in Table 1.
Crystal structure determination and refinement
The crystal structure of H-2K
b/gp34 was solved by molecular
replacement (MR) using Phaser [46] and the H-2K
b/GNYSFYAL
MHC complex (PDB code 1LK2) as a search model. Five percent
of the total reflections were set aside for monitoring refinement by
Rfree. The crystal structure of H-2K
b/NY-gp34 was solved
thereafter by MR using H-2K
b/gp34 as a search model.
Refinement of the two crystal structures was performed using
REFMAC5 [47]. After each round of refinement, missing residues
were added in successive cycles of manual building followed by
restrained refinement cycles in REFMAC5 [47]. The final
refinement parameters are presented in Table 1. Figures were
created using the program PyMOL [48].
Peptide-MHC binding affinity assays
Peptide-MHC binding affinity assays were performed using
transporter associated with antigen processing (TAP)-deficient
RMA-S cells as described previously [49], by assessing the capacity
of the different peptides to stabilize cell surface expression of H-
2K
b complexes. Briefly, 5610
5 RMA-S cells were pulsed with
different concentrations of indicated peptides in serum free AIM-V
medium (Invitrogen, Carlsbad, CA, USA) at 26uC overnight in
5% CO2. Cells were subsequently washed and incubated in AIM-
V medium at 37uC for 60 min in the absence of peptides. Cells
were then washed twice with PBS before staining with anti-H-2K
b
AF6-88.5 (BD PharMingen/BD Biosciences, MountainView, CA,
USA). Following washing and fixation in 1% PFA, H-2K
b cell
surface expression was detected by flow cytometry on BD
FACSCalibur (BD Biosciences). Flow cytometry data was analyzed
using Cell Quest Pro (BD Biosciences). The mean fluorescence
intensity (MFI) of H-2K
b expression for the indicated peptide
concentrations was divided by the observed MFI on cells without
peptide as an estimate of peptide binding. The HIV-derived H-
2D
d-restricted epitope P18 (RGPGRAFVTI) was used as a
negative control while the H-2K
b-restricted Moloney murine
leukemia virus peptide MULV (SSWDFITV) was used as a
positive control.
Assessment of MHC complex stability using circular
dichroism (CD) analysis
CD measurements were performed in 20 mM K2HPO4/
KH2PO4 (pH 7.5) using protein concentrations from 0.15 to
0.25 mg/ml. Spectra were recorded with a JASCO J-810
spectropolarimeter (JASCO Analytical Instruments, Great Dun-
mow, UK) equipped with a thermoelectric temperature controller
in a 2 mm cell. pMHC denaturation was measured between 30uC
and 75uC at 218 nm with a gradient of 48uC/hour at 0.1uC
increments and an averaging time of 8 seconds. The melting
curves were scaled from 0% to 100% and the Tm values extracted
as the temperature at 50% denaturation. Curves and Tm-values
are an average of at least two measurements from two independent
refolding assays per MHC complex. Spectra were analyzed using
GraphPad Prism 5 and Tm values compared using an unpaired,
two-tailored T test.
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analysis
Differential scanning fluorimetry experiments were carried out
using an iQ5 real-time PCR detection system (Bio-Rad). 96-well
PCR plates were filled with 23 ml of MHC solution (0.25 mg/mL)
in 10 mM Na
+ HEPES buffer (pH 7.3), 150 mM NaCl per well.
Finally, the fluorophore (2 ml of 1256 SYPRO Orange (Sigma
S5692)) was added to each well and the plate was sealed with
optical sealing tape (Bio-Rad). An iQ5 Real-Time PCR Detection
System, calibrated with External Well factor solution was used to
monitor the changes in fluorescence intensity of the fluorophore.
The temperature of the samples was changed from 20 to 95uCa ta
heating rate of 1uC/min and the fluorescence was recorded every
0.2uC. The melting temperature (Tm) of each melting curve was
calculated as the maximum of the first derivative of the curve. The
average Tm value of each protein was determined from three
distinct melting curves.
Molecular modeling of TCR in complex with wild-type
and nitro-tyrosinated MHC complexes
Molecular models of the TCR P14 in complex with H-2D
b/
gp33 or H-2D
b/NY-gp33 were created using previously described
protocols [50,51]. Interactions between P14 and each MHC
complex were analyzed visually for improper sterical contacts.
Docking of P14 on its MHC/peptide ligand was also assessed
according to contacts between evolutionary conserved amino acids
suggested to be important for TCR/MHC interaction [52]. The
molecular model was subjected to several rounds of energy
minimization using the CNS suite of programs [53]. The
coordinates of the TCR/MHC/peptide complexes will be
provided upon request.
Results and Discussion
Overall structures of H-2K
b in complex with wild-type
gp34 and nitrotyrosinated NY-gp34
The three dimensional structures of H-2K
b in complex with the
wild-type gp34 (AVYNFATM) and with the nitrotyrosinated NY-
gp34 (AV-p3NY-NFATM) were determined to 2.0 and 2.6 A ˚
resolutions, respectively (Table 1). Both crystal structures displayed
good stereochemistry. The final electron density maps are of good
quality with well-defined polypeptide chains (Figures 1A and 1B).
In particular, the electron densities for all H-2K
b residues in
contact with the peptides gp34 and NY-gp34 are clearly defined.
The overall three-dimensional structures of H-2K
b/gp34 and H-
2K
b/NY-gp34 are remarkably similar with a root mean square
deviation (rmsd) of 0.37 A ˚ 2 for the entire MHC complexes (heavy




PDB code 3ROO 3ROL
Cell parameters (A ˚) a=88.4, b=92.6, c=128.8, a=b=c=90.0 a=50.5, b=88.5, c=119.0, a=c=90.0, b=94.7
Data Collection
Space group P2 1 21 21 P12 1 2
Resolution range (A ˚) 57.3 – 2.0 50.3 – 2.6
Number of molecules/asymmetric unit 22
Number of reflections
Observed 338476 (47869) 138558 (20164)
Unique 72101 (10411) 32286 (4682)
I/s (I) 11.6 (2.6) 12.9 (3.3)
Completeness (%) 99.9 (100.0) 100.0 (100.0)
1Rsym (%) 8.3 (67.0) 11.9 (39.8)
Multiplicity 4.7 (4.6) 4.3 (4.3)
Refinement Statistics
2Rcryst(%) 22.5 24.7
3Rfree (%) 26.7 29.5
Number of protein atoms 6695 6391
Water/other molecules 396/4 283/4
rmsd from ideal geometry
Bond length (A ˚) 0.009 0.010
Bond angle (6) 1.136 1.285
Ramachandran Plot (%)
Residues in preferred regions 96.25 95.95
Residues in allowed regions 3.75 4.05
Non-glycine residues in disallowed regions 00
Values in parentheses are for the highest resolution shell.
1Rsym=ShSi|Ih,i2Ih|/ShSiIh,i, where Ih is the mean intensity of the i observations of symmetry related reflections of h.
2Rcryst=S|Fobs2Fcalc|/SFobs, where Fobs and Fcalc are the observed and the calculated structural factors, respectively.
3Rfree was calculated using 5% of the reflections.
doi:10.1371/journal.pone.0032805.t001
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of 0.27 A ˚ 2 for heavy chain residues 1–176 corresponding to the a1
and a2 domains.
Protrusion of residue p1K in H-2K
b/gp33 does not alter
the conformation of MHC residues within the N-terminal
part of the peptide-binding cleft
The previously determined crystal structure of H-2K
b in
complex with gp33 (KAVYNFATM) revealed that the nonameric
peptide binds to H-2K
b as an octamer with the stretch of residues
AVYNFATM filling the peptide-binding cleft, while the highly
flexible residue p1K extended out of the binding groove [50]
(Figure 2A). As for p2A in H-2K
b/gp33, the first peptide residue
p1A in both H-2K
b/gp34 (AVYNFATM) and H-2K
b/NY-gp34
(AV-p3NY-NFATM) is surrounded by a cluster of tyrosine
residues (Y7, Y159 and Y171) that forms a network of hydrogen
bond interactions with the nitrogen atom of p1A. However,
although the protrusion of p1K out of the peptide-binding cleft in
H-2K
b/gp33 results in a significant modification of the position of
the nitrogen atom of residue p2A when compared to p1A in H-
2K
b/gp34 or H-2K
b/NY-gp34, this does not affect the confor-
mation of the cluster of tyrosine residues that surround the N-
terminal part of the peptide (Figure 2B). Furthermore, the
conformation of the stretch of peptide residues AVYNFATM
bound within the peptide-binding cleft is very similar in both H-
2K
b/gp33 and H-2K
b/gp34 (Figure 2A). Thus although the N-
and C- peptide termini play crucial roles in binding of epitopes
within the peptide-binding cleft formed by the a1a2 groove [54],
these are not always necessarily required. It has been previously
demonstrated that longer peptides may protrude out of the groove
and that modified and/or shorter peptides can still bind efficiently
within the groove through the use of a network of water molecules
within the peptide binding cleft [50,55,56,57].
In the prior study by Hardy et al, T cells could be readily elicited
in C57/BL6 mice following immunization with NY-gp33 [37].
Figure 1. Crystal structures of H-2K
b in complex with gp34 and NY-gp34. Overall schematic views of the H-2K
b/gp34 and H-2K
b/NY-gp34
MHC complexes are presented in the left part of panels A and B. The a1, a2 and a3 domains of the MHC heavy chain are colored in white. The b2m
subunit is colored in green. The peptides are in blue. The 2Fo-Fc electron density maps for the peptides gp34 and NY-gp34 when bound to H-2K
b
presented in the right part of panels A and B, respectively, are contoured at 1.0 s. The final models are displayed for comparison. The peptides,
depicted with their N-termini to the left and their C-termini to the right, are displayed ‘from above’ as seen by the TCRs.
doi:10.1371/journal.pone.0032805.g001
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b/NY-gp33-specific CD8
+ T cell
hybridoma 24H1 recognized H-2K
b+ target cells coated with both
NY-gp33 and NY-gp34, it did not recognize H-2K
b/gp34 MHC
complexes. Furthermore, it should also be noted that 24H1 T cells
recognized H-2K
b/NY-gp34 to a higher level when compared to
H-2K
b/NY-gp33. The relatively lower recognition of H-2K
b/NY-
gp33 by 24H1 could be explained by the protrusion of the side
chain of p1K from the N-terminal part of the peptide-binding cleft
of H-2K
b/NY-gp33, which could potentially limit optimal




24H1 did not recognize H-2K
b/gp34?
Nitrotyrosination of peptide residue p3Y induces a
profound conformational change of the H-2K
b residue
E152, altering TCR recognition
The conformations of the peptides gp34 and NY-gp34 are very
similar when bound to H-2K
b, besides a lateral shift of 0.7 A ˚ of the
side chain of the nitrotyrosine p3NY in H-2K
b/NY-gp34 when
compared to the conformation of p3Y in H-2K
b/gp34 (Figure 3A).
In H-2K
b/gp34 the side-chain of p3Y projects down into the D-
pocket formed by residues Q114, E152, R155, L156 and Y159
(Figures 3A and 3B). Three hydrogen bond interactions are
formed between the side chain of p3Y and the side chains of the
H-2K
b residues E152 and R155 (Figure 3B). Nitrotyrosination of
p3Y alters only the conformation of the H-2K
b heavy chain
residue E152 which, in order to accommodate the side-chain of
p3NY, undergoes a large conformational modification in H-2K
b/
NY-gp34 when compared to H-2K
b/gp34 (Figure 3C). In
contrast, the rest of the H-2K
b peptide-binding groove is not
affected by the nitrotyrosination of the peptide in H-2K
b/NY-
gp34 when compared to H-2K
b/gp34.
In conclusion, substitution of the tyrosine residue at position 3 of
the peptide gp34 to a nitrotyrosine exclusively affects the
conformation of the side-chain of the H-2K
b residue E152. The
specificity of the T cell hybridoma 24H1 to H-2K
b/NY-gp34 thus
seems to be dependent on the conformation of the MHC region
surrounding the side-chains of p3NY and the H-2K
b residue
E152. It should be noted that previous studies have demonstrated
the importance of this region for recognition by H-2K
b-specific
TCRs [58,59]. One may thus speculate that nitrotyrosination of
the immunodominant peptide which alters considerably T cell
recognition may be advantageous for the virus in order to escape
immune recognition.
Nitrotyrosination of gp34 strains the overall
conformation of the H-2K
b complex and significantly
decreases its stability
Two additional interactions are formed between peptide residue
p3NY and the heavy chain residues Q114 and Y116 in the H-
2K
b/NY-gp34 peptide when compared to H-2K
b/gp34
(Figures 3B and 3C), suggesting that nitrotyrosination of the
peptide may result in higher stabilization capacity of H-2K
b
complexes by NY-gp34 when compared to gp34. However,
binding affinity assays using TAP-deficient cells demonstrated that
while both gp33 and gp34 displayed similar binding affinities to H-
2K
b, nitrotyrosination of peptide residue 3 significantly reduced
binding affinity of NY-gp34 to H-2K
b (Figure 4A).
Furthermore, the capacity of each peptide to stabilize H-2K
b
complexes was also investigated using circular dichroism (CD) by
assessing the thermostability of soluble H-2K
b molecules in
complex with gp34 or NY-gp34. Melting temperatures (Tm) were
derived from changes in ellipticity at 218 nm, corresponding to
loss of secondary structure during denaturation. Our analysis
demonstrates that the Tm value for H-2K
b/NY-gp34 (47.3uC) was
nearly 10uC lower than for H-2K
b/gp34 (56.7uC), reflecting the
significantly reduced capacity of NY-gp34 to stabilize H-2K
b
complexes (Figure 4B). Similar very significant shifts in thermal
stability were also obtained for the two MHC class I complexes
upon analyzing their stability with differential scanning fluorimetry
Figure 2. Protrusion of p1K in H-2K
b/gp33 does not affect the
overall conformation of the N-terminal part of the peptide
binding cleft and conserves the conformation of the epitopes.
A. Superimposed side views of the peptides gp33 (KAVYNFATM) and
gp34 (AVYNFATM) depicting how residue p1K in gp33 protrudes out of
the peptide binding cleft of H-2K
b. The remaining residues of gp33 take
a similar conformation to all the side chains of gp34. The peptides gp33
and gp34, annotated in black and cyan, respectively, are depicted with
their N termini to the left and their C termini to the right. The carbon
atoms of the peptides gp33 and gp34 are colored in white and cyan,
respectively. Carbon, nitrogen and oxygen atoms are in cyan, blue and
red, respectively. The peptide-binding cleft of H-2K
b is colored white. B.
Conformation of side chain residues interacting with the N-termini of
peptides in the crystal structures of H-2K
b/gp33 (in white) and H-2K
b/
gp34 (both MHC complexes from the asymmetric unit are displayed in
cyan and light green, respectively), following superposition of the a1a2
domains. Note that the p2A residue in gp33 occupies the position
corresponding to the p1A in gp34. The side chain of p1K in gp33 is not
displayed. The orientation of the peptides is depicted by a black arrow
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sponding to the mid-point of the sharp transition from folded to
unfolded state were 54.460.1 and 44.560.2 for H-2K
b/gp34 and
H-2K
b/NY-gp34 (Figure 4C). These significant differences in
stabilization capacity were at first surprising when considering that
additional hydrogen bonds and long ionic interactions are formed
between NY-gp34 and H-2K
b when compared to H-2K
b/gp34
(Figure 3C). However, further comparative analysis of the two
crystal structures provided an explanation to these unexpected
results.
In H-2K
b/NY-gp34, the side-chain of the nitrotyrosine p3NY
projects within the D-pocket of H-2K
b, resulting in structural over-
packing (Figures 3A and 3C) and a ‘strained’ overall conformation
of the MHC complex. Although this has not, to our knowledge, yet
been reported for MHC class I molecules, strained conformations
are relatively common and have been described for several
proteins including e.g. native serine protease inhibitors [61] and
spectrin SH3 core-domains [62]. Induction of strained conforma-
tions is also important within several processes including catalysis
in thymidylate synthase [63] and nuclear transport of exportins
[64]. Proteins with strained ‘spring-loaded’ conformations are
usually intrinsically unstable. For example, the release of the
course of the strained conformation in circularly permutated
barnases resulted in a 20uC shift in melting temperature [65] or in
a 25-fold increase in stability for mutated serpins [66]. In the
crystal structure of the H-2K
b/NY-gp34 complex, introduction of
the side chain of p3NY resulted in close contacts between the
nitrotyrosinated peptide and several H-2K
b residues, forcing them
away from the relaxed low-energy conformation observed in H-
2K
b/gp34 in order to accommodate the side chain of p3NY, thus
resulting in unfavorable strained conformations. Besides straining
the backbone of the heavy chain residues 124–126 and 156–157,
the side chain of p3NY also incurred strained higher internal
energy conformations for the side-chains of residues V97, I98 and
Q114, when compared to H-2K
b/gp34.
In conclusion, the potential gain in enthalpy resulting from the
formation of two additional interactions between p3NY and the
H-2K
b residues Q114 and Y116 may be outweighed by the loss of
a hydrogen bond interaction formed with the side chain of E152
combined with the free energy cost resulting from the strained
conformations of several MHC residues. Our results indicate that
formation of additional interactions between peptides and MHC
residues does not always necessarily increase the overall stabiliza-
tion of MHC complexes. Furthermore, alteration of MHC
complex stabilization through nitrotyrosination of the presented
epitope may represent an additional alternative strategy used by
the virus to prevent adequate presentation of the peptide at the
surface of the infected cell.
Nitrotyrosination of p4Y in H-2D
b/NY-gp33 directly
affects recognition by H-2D
b/gp33-specific TCRs
The previously determined crystal structures of H-2D
b and H-
2K
b in complex with gp33 demonstrated that the peptide binds in
two diametrically opposed manners to the two MHC class I
molecules [50]. Thus in contrast to H-2K
b/gp33 and H-2K
b/
gp34, in which the side-chain of the tyrosine residue acts as a
secondary anchor position, the side-chain of p4Y in H-2D
b/gp33
protrudes out of the peptide-binding cleft, playing a key role in
TCR recognition [41,43,50]. Indeed, mutation of p4Y to a
Figure 3. Nitrotyrosination of peptide residue p3Y results in a
conformational change of the side-chain of the H-2K
b residue
E152 only, altering TCR recognition. A. Superposition of the
peptide-binding clefts of H-2K
b/gp34 and H-2K
b/NY-gp34 demonstrate
a subtle shift of the side chain of p3NY when compared to p3Y,
resulting in a significant conformational change of the TCR-interacting
H-2K
b heavy chain residue E152 (underlined). Both side chains of
residues p3Y and p3NY protrude in the D-pocket of H-2K
b consisting of
residues W147, E152, R155, L156 and Y159. The gp34 and NY-gp34
peptides are colored cyan and light green, respectively. B. Side view of
the peptide gp34 when bound to H-2K
b. Three hydrogen bond
interactions are formed between p3Y and the H-2K
b residues E152 and
R155. No interactions are observed with the H-2K
b residues Q114 and
Y116. C. A novel hydrogen bond and a long ionic range interaction are
formed between p3NY and the H-2K
b residues Q114 and Y116,
respectively. While two hydrogen bond interactions are maintained
between p3NY and R155, all interactions are lost with E152.
doi:10.1371/journal.pone.0032805.g003
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both its binding affinity and stabilization capacity of the H-2K
b
complex. A. The binding affinity of NY-gp34to H-2K
bon the surface of
TAP-deficient RMA-S cells was significantly reduced when compared to
gp33 and gp34. Cells were incubated with the indicated concentrations
of each peptide at 26uC for 12 hours in 5% CO2. Cells were collected
and stained with the H-2K
b-specific antibody AF6-88.5. The mean
fluorescence intensities (MFI) observed for each timepoint were
normalized as described in the peptide binding affinity assays outlined
above. The H-2D
d and H-2D
b-restricted peptides P18-I10 and MulV were
used as negative and positive controls, respectively. The peptide
binding assays were repeated three times. B. The capacity of NY-gp34
to stabilize soluble H-2K
b complexes is significantly reduced when
compared to gp34. MHC complex melting temperatures (Tm) were
measured using circular dichroism. Tm values were derived from
normalized thermal denaturation curves for the MHC complexes H-2K
b/
gp34 (in grey) and H-2K
b/NY-gp34 (in black) as the temperature
corresponding to 50% denaturation (dashed line). The presented
denaturation curves are an average from at least two independent
measurements for each MHC complex. C. The denaturation curves of
the two MHC complexes, using the differential scanning fluorimetry
approach (thermofluor), are consistent with the two-state model of
thermal unfolding. The melting temperatures, defined as the inflection
points of the escalating parts of the curves, the curves of H-2K
b/gp34
and H-2K
b/NY-gp34 are in grey and black, respectively.
doi:10.1371/journal.pone.0032805.g004
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b/gp33-
specific TCR P14 by 100-fold [51,67]. A molecular model of P14
in complex with the crystal structure of H-2D
b/gp33 indicated
that the side-chain of the protruding p4Y is perfectly positioned in
the hotspot of the TCR composed of the CDR3 loops from both
the Va and Vb domains. It forms three hydrogen bonds with the
TCR residues Y36(Va) and G102(Vb), as well as with the side
chain of the H-2D
b histidine residue H155, linking this domain of
the heavy chain to the TCR (Figure 5A). In contrast, insertion of
the negatively charged NO2 group in p4NY would result in
deleterious sterical clashes with Y36(Va) or G102(Vb) (Figures 5B
and 5C). The side chain of one of the possible p4NY rotamers
would also repulse the negatively charged side-chain of the MHC
residue E163, important for TCR recognition (Figure 5B).
In conclusion, nitrotyrosination of p4Y in H-2D
b/NY-gp33 is
clearly deleterious for recognition by P14 as previously demon-
strated [37]. Thus, one may here speculate again about the
possibility that nitrotyrosination of the H-2D
b-restricted peptide
gp33 may represent an important strategy used by LCMV in order
to avoid CD8
+ T cell recognition and escape immune recognition.
Furthermore, and as for H-2K
b/NY-gp34, our structural analysis
also strongly indicates that NY-gp33 may act as an H-2D
b-
restricted neo-epitope with the capacity to break tolerance,
selecting and inducing inadequate T cell responses that may
result in autoreactivity.
Concluding remarks
Our study provides a structural platform underlying the effects
of peptide nitrotyrosination on initiation of TCR responses. Such
PTMs can directly affect TCR recognition by modifying the
properties of key TCR-interacting residues on the presented
peptide or by altering the conformations of other MHC residues
that are of importance for TCR recognition. Nitrotyrosination can
also indirectly affect TCR recognition by severely destabilizing the
MHC complex. Although additional interactions were formed
between the PTM peptide and H-2K
b, the conformation of a large
amount of surrounding residues was strained, significantly
reducing the overall stability of the MHC complex. We have
previously demonstrated that subtle modifications in MHC-
restricted peptides can result in significant alterations of MHC
stabilization [51], a phenomenon that should be taken into
account and measured upon trying to design altered peptide
ligands for modulation of TCR response [49,68]. Several other
amino acid modifications caused by oxidative stress could result in
similar effects on TCR recognition [69,70]. In conclusion, our
structural study indicates that the impact of post-translational
modifications could be dual, possibly allowing for viral immune
escape from TCR recognition but also potentially inducing the
expansion of subset of T cells that could induce autoreactivity.
Likewise, nitrotyrosination of self-peptides during periods of
inflammation or oxidative stress could lead to the formation of
neo-epitopes that, through the same mechanisms described herein
for gp33/34, could escape the constraints of central tolerance. The
impact of these modified de-novo MHC complexes on the initiation
of unwanted T cell responses that may result in autoreactivity
remains to be studied.
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